Cellectis (CLLS) Cash & Equivalents (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -57.05% |
| Sep 30, 2025 | 139.51% |
| Jun 30, 2025 | -53.14% |
| Mar 31, 2025 | -10.90% |
| Dec 31, 2024 | 4.79% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 46.66% |
| Sep 30, 2023 | 10.46% |
| Jun 30, 2023 | 1.04% |
| Mar 31, 2023 | -10.41% |
| Dec 31, 2022 | -4.54% |
| Sep 30, 2022 | -24.56% |
| Jun 30, 2022 | -16.42% |
| Mar 31, 2022 | -16.57% |
| Dec 31, 2021 | -11.90% |
| Sep 30, 2021 | -15.11% |
| Jun 30, 2021 | 2.94% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -7.59% |
| Sep 30, 2020 | -23.37% |
| Jun 30, 2020 | 18.59% |
| Mar 31, 2020 | -15.68% |
| Dec 31, 2019 | -0.57% |
| Sep 30, 2019 | -24.15% |
| Jun 30, 2019 | 7.13% |
| Mar 31, 2019 | -6.65% |
| Dec 31, 2018 | -5.10% |
| Sep 30, 2018 | 0.97% |
| Jun 30, 2018 | 83.80% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | -2.84% |
| Sep 30, 2017 | 3.65% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -2.37% |
| Dec 31, 2016 | -23.78% |
| Sep 30, 2016 | -3.64% |
| Jun 30, 2016 | 2.44% |
| Mar 31, 2016 | 0.63% |
| Dec 31, 2015 | 175.64% |
| Sep 30, 2015 | 0.65% |
| Jun 30, 2015 | -2.19% |
| Mar 31, 2015 | 1,243.57% |